CHIRRA, MARTINA
CHIRRA, MARTINA
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.0 secondi).
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy
2018-01-01 Petrioli, Roberto; Chirra, Martina; Messuti, Luciana; Fiaschi, Anna Ida; Savelli, Vinno; Martellucci, Ignazio; Francini, Edoardo
Extramammary invasive Paget’s disease and apocrine angiomatous hamartoma: an unusual association
2018-01-01 Miracco, C.; Francini, E.; Torre, P.; Baldino, G.; Chirra, M.; Cinotti, E.; Francini, G.
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer
2019-01-01 Petrioli, R.; Marrelli, D.; Roviello, F.; D'Ignazio, A.; Torre, P.; Chirra, M.; Savelli, V.; Ambrosio, M. R.; Francini, G.; Calomino, N.; Farsi, M.; Vernillo, R.; Francini, E.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy | 1-gen-2018 | Petrioli, Roberto; Chirra, Martina; Messuti, Luciana; Fiaschi, Anna Ida; Savelli, Vinno; Martellucci, Ignazio; Francini, Edoardo | - | |
| Extramammary invasive Paget’s disease and apocrine angiomatous hamartoma: an unusual association | 1-gen-2018 | Miracco, C.; Francini, E.; Torre, P.; Baldino, G.; Chirra, M.; Cinotti, E.; Francini, G. | - | |
| Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer | 1-gen-2019 | Petrioli, R.; Marrelli, D.; Roviello, F.; D'Ignazio, A.; Torre, P.; Chirra, M.; Savelli, V.; Ambrosio, M. R.; Francini, G.; Calomino, N.; Farsi, M.; Vernillo, R.; Francini, E. | - |